Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
13 September 2024
Closed
Estimated Value
£1,200,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £1,200,000,000 |
| Release Date: | 20 January 2025 |
| Application Deadline: | 13 September 2024 |
| Contract Start Date: | 31 March 2025 |
| Contract End Date: | 31 December 2027 |
| Contract Duration: | 2.8 years |
| Procurement ID (OCID): | ocds-b5fd17-63eefe2c-af75-4320-8392-e35c49eff8b9 |
| Notice Reference: | f50849d8-e3d7-4276-ac88-5f2c44b2218e-818682 |
View Original Notice
Access the full notice on the official portal
Awarded to (6 suppliers)
| Award value: | £905,187,090 |
| Award decision date: | 19 December 2024 |
| Award status: | Active |
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories